Filtered By:
Specialty: Cardiology
Drug: Zetia
Management: Health Insurance
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction
ConclusionImplementation of guideline-recommended cholesterol-lowering therapy could prevent a substantial percentage of recurrent ASCVD events.
Source: Cardiovascular Drugs and Therapy - April 13, 2023 Category: Cardiology Source Type: research
